Carperitide (PharmaIN)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameCarperitide (PharmaIN)
Drug Alias NameAtrial natriuretic peptide (PharmaIN)
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionAtrial natriuretic peptide receptor agonistsFibrinogen inhibitors
TargetsAtrial natriuretic peptide receptorFibrinogen
Therapy Area/IndicationsHeart FailureLiver CirrhosisNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesPharmaIN Corp
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesPharmaIN Corp
Active IndicationsN/A
Inactive IndicationsHeart FailureLiver CirrhosisNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A